rs2622867

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001854.4(COL11A1):​c.2295+37A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.959 in 1,612,872 control chromosomes in the GnomAD database, including 743,440 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.92 ( 64681 hom., cov: 33)
Exomes 𝑓: 0.96 ( 678759 hom. )

Consequence

COL11A1
NM_001854.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.599

Publications

13 publications found
Variant links:
Genes affected
COL11A1 (HGNC:2186): (collagen type XI alpha 1 chain) This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Mutations in this gene are associated with type II Stickler syndrome and with Marshall syndrome. A single-nucleotide polymorphism in this gene is also associated with susceptibility to lumbar disc herniation. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Nov 2009]
COL11A1 Gene-Disease associations (from GenCC):
  • Marshall syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • Stickler syndrome type 2
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, PanelApp Australia, Orphanet, Genomics England PanelApp
  • fibrochondrogenesis 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • hearing loss, autosomal dominant 37
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • fibrochondrogenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive Stickler syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 1-102995952-T-A is Benign according to our data. Variant chr1-102995952-T-A is described in ClinVar as Benign. ClinVar VariationId is 258443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.977 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL11A1NM_001854.4 linkc.2295+37A>T intron_variant Intron 27 of 66 ENST00000370096.9 NP_001845.3 P12107-1Q59HB5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL11A1ENST00000370096.9 linkc.2295+37A>T intron_variant Intron 27 of 66 1 NM_001854.4 ENSP00000359114.3 P12107-1

Frequencies

GnomAD3 genomes
AF:
0.919
AC:
139762
AN:
152146
Hom.:
64633
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.800
Gnomad AMI
AF:
0.999
Gnomad AMR
AF:
0.953
Gnomad ASJ
AF:
0.904
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.986
Gnomad FIN
AF:
0.969
Gnomad MID
AF:
0.937
Gnomad NFE
AF:
0.964
Gnomad OTH
AF:
0.910
GnomAD2 exomes
AF:
0.956
AC:
240007
AN:
250946
AF XY:
0.961
show subpopulations
Gnomad AFR exome
AF:
0.791
Gnomad AMR exome
AF:
0.972
Gnomad ASJ exome
AF:
0.896
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
0.970
Gnomad NFE exome
AF:
0.963
Gnomad OTH exome
AF:
0.951
GnomAD4 exome
AF:
0.964
AC:
1407358
AN:
1460608
Hom.:
678759
Cov.:
43
AF XY:
0.965
AC XY:
701033
AN XY:
726654
show subpopulations
African (AFR)
AF:
0.787
AC:
26316
AN:
33424
American (AMR)
AF:
0.969
AC:
43240
AN:
44640
Ashkenazi Jewish (ASJ)
AF:
0.896
AC:
23391
AN:
26106
East Asian (EAS)
AF:
1.00
AC:
39637
AN:
39638
South Asian (SAS)
AF:
0.987
AC:
85070
AN:
86222
European-Finnish (FIN)
AF:
0.970
AC:
51782
AN:
53400
Middle Eastern (MID)
AF:
0.941
AC:
5294
AN:
5626
European-Non Finnish (NFE)
AF:
0.967
AC:
1075097
AN:
1111220
Other (OTH)
AF:
0.954
AC:
57531
AN:
60332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
2874
5748
8623
11497
14371
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21618
43236
64854
86472
108090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.919
AC:
139868
AN:
152264
Hom.:
64681
Cov.:
33
AF XY:
0.922
AC XY:
68624
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.800
AC:
33219
AN:
41528
American (AMR)
AF:
0.953
AC:
14567
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.904
AC:
3139
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5184
AN:
5184
South Asian (SAS)
AF:
0.986
AC:
4759
AN:
4828
European-Finnish (FIN)
AF:
0.969
AC:
10293
AN:
10620
Middle Eastern (MID)
AF:
0.942
AC:
277
AN:
294
European-Non Finnish (NFE)
AF:
0.964
AC:
65594
AN:
68026
Other (OTH)
AF:
0.911
AC:
1925
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
557
1113
1670
2226
2783
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
906
1812
2718
3624
4530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.937
Hom.:
12325
Bravo
AF:
0.912
Asia WGS
AF:
0.983
AC:
3414
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hearing loss, autosomal dominant 37 Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Marshall syndrome Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fibrochondrogenesis 1 Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Stickler syndrome type 2 Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
0.39
DANN
Benign
0.52
PhyloP100
-0.60
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2622867; hg19: chr1-103461508; API